NCT00325715View on ClinicalTrials.gov

AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Peptic Ulcer
Interventions
DRUG

AGN 201904

DRUG

esomeprazole

Trial Locations (1)

Unknown

Houston

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY